タダラフィル(Tadalafil) Mylan社製の個人輸入はベストドラッグへ
Farmaceutica, i generici di Teva lanciano una maxi offerta da 40,1 miliardi per Mylan - la Repubblica
Teva prices EpiPen generic at $300, same price as Mylan generic-Business News , Firstpost
Teva Pharmaceutical Industries' quest to acquire Mylan NV could wind up in a Dutch court - Pittsburgh Business Times
Teva/Mylan: brand management | Financial Times
FDA swats down Teva's EpiPen copy, putting Mylan in cruise control | Fierce Pharma
How a Teva-Mylan deal will affect Indian pharma companies | Mint
US lawmakers push Mylan, Teva over drug pricing probe - www.israelhayom.com
Exclusive: Teva, Mylan Eye Pfizer's Brazil Venture, Sources Say
Consumer groups condemn Teva-Mylan deal - Pittsburgh Business Times
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Mylan share price plunges after Teva abandons bid | Financial Times
With Teva Bid Off the Table, Mylan's Stock In 'Show-Me' Mode - WSJ
Mylan makes hostile $31.2 billion Perrigo bid to thwart Teva | Mint
イスラエルのTeva Pharmaceuticals、同業のMylanに買収提案 - 化学業界の話題
Valsartan recall expands to Mylan, Teva products | Fierce Pharma
Mylan regina dei titoli farmaceutici a Wall Street. Crollano Teva e Momenta - Economia e Finanza - Repubblica.it
Farmaceutico: Teva ci riprova con Mylan, verso rialzo offerta fino almeno a 43 mld $
Teva's Generic EpiPen Will Cost As Much As Mylan's Generic | Time
Teva makes $40 billion offer for Mylan
Teva loses Copaxone patent dispute case to Mylan in UK - Pharmaceutical Business review
How Mylan tried to keep Teva from selling a generic EpiPen
Teva offers to buy Mylan in $40 billion deal | The Times of Israel
Mylan surprises analysts, Teva with long-delayed Copaxone approvals | Fierce Pharma
$40B deal: Teva offers to buy Mylan
